Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02053493 · ClinicalTrials.gov registry record · Phase 2
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
A Phase 2 study, sponsored by Adrian Hernandez.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT02053493 is a Phase 2 study that has completed, run by Adrian Hernandez. The registered enrollment target is 110 participants.
The verdict
NCT02053493, a Phase 2 study, has completed, sponsored by Adrian Hernandez.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
A randomized, double-blinded, placebo-controlled crossover study to assess effect of isosorbide mononitrate with dose up-titration on activity tolerance as assessed by (hip-worn, tri-axial) accelerometry.
Interventions
- DRUG Placebo
- DRUG Isosorbide Mononitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02053493
The ClinicalTrials.gov registry entry for NCT02053493 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adrian Hernandez, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02053493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02053493 about?
NCT02053493 is a clinical study titled "Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction". A randomized, double-blinded, placebo-controlled crossover study to assess effect of isosorbide mononitrate with dose up-titration on activity tolerance as assessed by (hip-worn, tri-axial) accelerometry.
What is the current status of trial NCT02053493?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2014-04. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02053493?
The interventions under investigation include: Placebo (DRUG), Isosorbide Mononitrate (DRUG).
Who is sponsoring clinical trial NCT02053493?
This trial is sponsored by Adrian Hernandez, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.